4//SEC Filing
Flynn Paul R 4
Accession 0001093557-21-000290
CIK 0001093557other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:40 PM ET
Size
5.3 KB
Accession
0001093557-21-000290
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Flynn Paul R
EVP, Global Revenue
Transactions
- Award
Common Stock
2021-12-15$0.00/sh+2,925$3→ 13,853 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/2 shall vest 24 months from the Grant Date, 1/8 shall vest 27 months from the Grant Date, 1/8 shall vest 30 months from the grant date, 1/8 shall vest 33 months from the Grant Date, and the remaining balance shall vest 36 months from the Grant Date. Share units represent a contingent right to receive one share of DexCom Inc. Common Stock.
- [F2]Included in this number are 13,853 unvested restricted stock units, 2,925 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001850141
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:40 PM ET
- Size
- 5.3 KB